People With Age-Related Macular Degeneration More Prone To Severe COVID-19: Know Why
People With Age-Related Macular Degeneration More Prone To Severe COVID-19: Know Why
Growing evidence suggests that AMD patients have increased risk for COVID-19 infection and mortality. Boston University researchers have identified a novel association between the two diseases.
We know that the novel coronavirus affects different people differently. Some people infected with COVID-19 are symptomatic and there are groups who get sicker than others. The high-risk groups include people with chronic illnesses and those with weakened immune system. COVID-19 infections can be dangerous for people with age-related macular degeneration (AMD), an eye disease that can affect the central vision, as well. Caused by damage to the macula (a part of the retina), AMD is a leading cause of vision loss among older adults.
Growing evidence suggests that AMD a risk factor for increased risk for COVID-19 infection, severe complications due to the disease, including respiratory failure and death. Lending credence to previous findings, a study by researchers from the Boston University suggested that "this increased risk may have a genetic basis."
COVID-19 and Age-Related Macular Degeneration (AMD)
The BU research team identified a novel association between AMD and COVID-19 with variants in a gene that encodes a platelet derived growth factor (PDGF). This growth factor helps in the formation of new blood vessels, and it is also associated with abnormal blood vessel changes that occur in age-related macular degeneration.
As per the researchers, the association between age-related macular degeneration and more severe COVID-19 outcomes appears to be due to genetic predisposition to dysfunction involving complement proteins and a higher level of PDGF in blood serum. These findings were reported in the online Journal of Clinical Medicine.
How to reduce the risk for COVID-19 severity in AMD patients
The BU researchers believe that lowering PDGFB gene activity and PDGF concentration in blood may help reduce the severity of COVID-19, particularly among older patients.
Add The Health Site as a Preferred Source
Disclaimer: The content on TheHealthSite.com is only for informational purposes. It is not at all professional medical advice. Always consult your doctor or a healthcare specialist for any questions regarding your health or a medical condition.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. Cookie Policy.